Illumina, Inc. (LON:0J8Z)
London flag London · Delayed Price · Currency is GBP · Price in USD
113.63
-3.33 (-2.84%)
Feb 12, 2026, 5:00 PM GMT

Illumina Revenue

In the year 2025, Illumina had annual revenue of $4.34B USD, down -0.66%. Illumina had revenue of $1.16B in the quarter ending December 28, 2025, with 4.98% growth.

Revenue
$4.34B
Revenue Growth
-0.66%
P/S Ratio
4.05
Revenue / Employee
$480.95K
Employees
9,030
Market Cap
13.03B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20254.34B-29.00M-0.66%
Dec 29, 20244.37B-132.00M-2.93%
Dec 31, 20234.50B-80.00M-1.75%
Jan 1, 20234.58B58.00M1.28%
Jan 2, 20224.53B1.29B39.73%
Jan 3, 20213.24B-304.00M-8.58%
Dec 29, 20193.54B210.00M6.30%
Dec 30, 20183.33B581.00M21.11%
Dec 31, 20172.75B354.00M14.76%
Jan 1, 20172.40B178.00M8.02%
Jan 3, 20162.22B358.64M19.27%
Dec 28, 20141.86B440.18M30.97%
Dec 29, 20131.42B272.66M23.74%
Dec 30, 20121.15B92.98M8.81%
Jan 1, 20121.06B152.79M16.93%
Jan 2, 2011902.74M236.42M35.48%
Jan 3, 2010666.32M93.10M16.24%
Dec 28, 2008573.23M206.43M56.28%
Dec 30, 2007366.80M182.21M98.71%
Dec 31, 2006184.59M111.09M151.13%
Jan 1, 200673.50M22.92M45.31%
Jan 2, 200550.58M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.67B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
CVS Group673.20M
Genus672.80M
Revenue Rankings